1
|
Miyata K, Sukata T, Kushida M, Ogata K, Suzuki M, Ozaki M, Ozaki K, Uwagawa S. Spontaneous iron accumulation in hepatocytes of a 7-week-old female rat. J Toxicol Pathol 2009; 22:199-203. [PMID: 22271995 PMCID: PMC3252042 DOI: 10.1293/tox.22.199] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2009] [Accepted: 06/08/2009] [Indexed: 11/19/2022] Open
Abstract
Spontaneous iron accumulation in hepatocytes was observed in a 7-week-old female Han Wistar GALAS rat. Very fine yellowish brown pigments, which showed a positive reaction with Berlin Blue stain, were apparent in the cytoplasm close to the bile canaliculi, with a diminishing periportal-to-centrilobular gradient. There were also differences in distribution between and within lobes. Transmission electron microscopy revealed cytosolic ferritin and pericanalicular siderosomes in hepatocytes. No degeneration or necrotic changes were observed, and non-hepatocyte cells did not demonstrate any obvious accumulation of iron. There were no abnormalities in the animal other than this finding in the liver.
Collapse
Affiliation(s)
- Kaori Miyata
- Environmental Health Science Lab., Sumitomo Chemical Co., Ltd., 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan
| | - Tokuo Sukata
- Environmental Health Science Lab., Sumitomo Chemical Co., Ltd., 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan
| | - Masahiko Kushida
- Environmental Health Science Lab., Sumitomo Chemical Co., Ltd., 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan
| | - Keiko Ogata
- Environmental Health Science Lab., Sumitomo Chemical Co., Ltd., 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan
| | - Manabu Suzuki
- Animal Clinic Support Center, Sumika Technoservice Corporation, 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-8558 Japan
| | - Masakazu Ozaki
- Animal Clinic Support Center, Sumika Technoservice Corporation, 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-8558 Japan
| | - Keisuke Ozaki
- Environmental Health Science Lab., Sumitomo Chemical Co., Ltd., 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan
| | - Satoshi Uwagawa
- Environmental Health Science Lab., Sumitomo Chemical Co., Ltd., 1–98, Kasugadenaka 3-chome, Konohana-ku, Osaka 554-8558, Japan
| |
Collapse
|
2
|
Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: A frequently underestimated combination. World J Gastroenterol 2009; 15:3462-71. [PMID: 19630099 PMCID: PMC2715970 DOI: 10.3748/wjg.15.3462] [Citation(s) in RCA: 75] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Alcoholic liver disease (ALD) and hepatitis C virus (HCV) infection represent, either alone or in combination, more than two thirds of all patients with liver disease in the Western world. This review discusses the epidemiology and combined impact of ALD and HCV on the progression of liver disease. ALD and HCV affect the progression of liver disease to liver cirrhosis and hepatocellular carcinoma (HCC) in a synergistic manner. Thus, the risk for HCC increases five times with a daily alcohol consumption of 80 g; in the presence of HCV it is increased 20-fold, and a combination of both risk factors leads to a more than 100-fold risk for HCC development. Alcohol consumption also decreases the response to interferon treatment which is probably due to a lack of compliance than a direct effect on HCV replication. Several molecular mechanisms are discussed that could explain the synergistic interaction of alcohol and HCV on disease progression. They include modulation of the immune response and apoptosis, increased oxidative stress via induction of CYP2E1 and the hepatic accumulation of iron. Thus, both HCV and alcohol independently cause hepatic iron accumulation in > 50% of patients probably due to suppression of the liver-secreted systemic iron hormone hepcidin. A better understanding of hepcidin regulation could help in developing novel therapeutic approaches to treat the chronic disease in the future. For now, it can be generally concluded that HCV-infected patients should abstain from alcohol and alcoholics should be encouraged to participate in detoxification programs.
Collapse
|
4
|
Abstract
The early stages of hepatocarcinogenesis in human chronic liver diseases are characterized by the emergence of preneoplastic lesions of which some will eventually develop into hepatocellular carcinoma (HCC). Basic studies on the genetic and epigenetic alterations of these preneoplastic lesions may eventually lead to new therapeutic strategies. Clinicopathological studies are also important in order to determine optimal management of patients with a preneoplastic lesion. This article aims to provide a comprehensive review of the current concepts of preneoplastic lesion in chronic liver diseases. The microscopical small-cell dysplastic focus is the smallest morphologically recognizable precursor lesion of HCC and therefore is a logical target of study to elucidate the earliest events in hepatocarcinogenesis. In contrast, large-cell dysplasia is not a precursor lesion, but appears to be of clinical value because of its good predictive value for development of HCC. Dysplastic nodules (DNs) are macroscopically recognizable precursor lesions of HCC and high-grade DNs (HGDNs) have a risk of malignant transformation. Detection of DNs and correct differentiation from small HCC (<2 cm) is sometimes difficult, especially when only imaging techniques are used. Additional clinicopathological studies on identification and optimal treatment of DNs are necessary. Molecular studies on HGDNs and small HCCs may yield much information on the genetic mechanisms involved in the transition from severe dysplasia to early malignancy. In contrast, currently available data indicate that (large) regenerative nodules do not represent a distinct step in hepatocarcinogenesis. Animal models will be helpful in the further unravelling of human HCC development, provided that studies are performed on models that are good representatives of human hepatocarcinogenesis. We propose three criteria by which good mimickers can be identified.
Collapse
Affiliation(s)
- Louis Libbrecht
- Liver Research Unit of the Laboratory of Morphology and Molecular Pathology, Department of Pathology, University and University Hospitals of Leuven, 3000 Leuven, Belgium.
| | | | | |
Collapse
|
5
|
Pirisi M, Scott CA, Avellini C, Toniutto P, Fabris C, Soardo G, Beltrami CA, Bartoli E. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations. Am J Clin Pathol 2000; 113:546-54. [PMID: 10761457 DOI: 10.1309/trb1-jxuj-l9r6-9nhx] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
Histologically detectable iron (HDI) and HFE mutations were searched for in liver biopsy specimens from 58 Italian patients with chronic hepatitis C, and morphologic features were compared to examine their reciprocal relation and their contribution to disease progression. HDI was evident in 48% of cases with features of nonhemochromatosis iron overload. Total, sinusoidal, and portal HDI increased with stage; grade was related to all iron scores because of the contribution of portal inflammation and interface hepatitis. HFE mutations were seen in 47% of patients with chronic hepatitis C and in 28% of control subjects; they were related to stage and the His63Asp mutation to portal HDI. On multivariate analysis, grade but not stage or HFE mutations was associated with HDI in all sites. Interface hepatitis with its sequelae (sinusoidal capillarization and microshunting) represents a major factor in iron deposition in chronic hepatitis C and justifies the features of HDI. HFE mutations are not responsible for HDI deposition but could favor the progression of virus-induced damage independently from interference with iron metabolism.
Collapse
Affiliation(s)
- M Pirisi
- Department of Clinical and Experimental Pathology, University of Udine, Italy
| | | | | | | | | | | | | | | |
Collapse
|